Manufacturing Process Development for Belzutifan, Part 2: a Continuous Flow Visible-light-induced Benzylic Bromination

WuXi STA scientists and partner Merck recently published this OPRD paper discussing how photochemistry and continuous processing technology (flow chemistry) enabled the development of robust and greener commercial-scale manufacturing process for the novel oncology therapy Belzutifan (MK-6482).

View now